OPCH vs. PNTG: Which Stock Is the Better Value Option? Zacks Equity Research Aug 7, 2026 OPCH vs. PNTG: Which Stock Is the Better Value Option?
BTSG Raises 2026 Guidance as Specialty and Home Health Drive Growth Urbi Guha Aug 4, 2026 BrightSpring beat second-quarter estimates and raised its 2026 outlook as specialty, infusion and home health growth lifted margins and EBITDA.
Is BTSG a Buy as Rapid Growth Collides With Its Premium Valuation? Urbi Guha Aug 4, 2026 BrightSpring's broad-based growth and margin gains strengthen its outlook, but a premium valuation leaves little room for execution missteps.
BTSG Drops 18.1% in One Week as Growth Meets Fresh Valuation Risks Urbi Guha Aug 4, 2026 BrightSpring's 18.1% weekly slide clashes with strong growth and raised guidance as valuation, policy and integration risks test the rebound case.
